Exc f/e/e/n/l mal+mrg 0.6-1
CPT 11641 covers the surgical removal of a malignant (cancerous) skin lesion measuring 0.6 to 1.0 centimeters on the face, ears, eyelids, nose, or lips, including a margin of healthy tissue around it.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Measure the lesion diameter PLUS margins in the pathology report, not just clinical pre-excision size, to determine correct code selection
Impact: Upcoding from 11640 (≤0.5cm, $181.76) to 11641 ($229.98) represents $48.22 (26.5%) increase; documentation must support excised diameter
Document anatomic location precisely using facial subsite terminology (nasal ala, upper cutaneous lip, helix of ear) rather than generic 'face' to withstand audits
Impact: Prevents downcoding to non-facial excision codes (11600-11606 series) which pay approximately 30-40% less due to lower complexity
Bill intermediate (12051-12057) or complex closure (13151-13153) separately when layered repair or undermining is performed; simple closure is bundled
Impact: Additional $150-400+ depending on closure complexity and size; requires documentation of technique (layered, undermining, extensive debridement)
For multiple lesions excised same session, bill largest lesion at full code (11641) and additional lesions with modifier 59 using size-appropriate codes
Impact: Second lesion typically paid at 50% ($114.99 for facility, $76.02 for non-facility); proper sequencing maximizes reimbursement
Choose place of service carefully: office (11) vs. ASC (24) vs. hospital outpatient (22) affects facility vs. non-facility rate difference of $77.95 per excision
Impact: Non-facility rate $229.98 vs. facility rate $152.03; performing in office when safe increases physician payment by 51.3%
Submit pathology report with claim for malignant diagnosis (C44.x codes) to prevent denials; payers often request to verify medical necessity
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.